Low testosterone has two fundamentally different origins: primary hypogonadism (testicular failure — the testes can't produce testosterone even when properly signaled) and secondary hypogonadism (hypogonadotropic hypogonadism — the hypothalamus or pituitary fails to send the LH signal that commands testosterone production). The distinction matters clinically because the causes, workup, and sometimes treatment differ significantly.
Primary vs. Secondary: The LH Test
The key diagnostic test: measure LH alongside testosterone. Primary hypogonadism: low testosterone + high LH (pituitary working hard to stimulate failing testes). Secondary hypogonadism: low testosterone + low or normal LH (pituitary not sending adequate signal). A low T + low/normal LH combination requires investigation of pituitary and hypothalamic causes — it's not 'just aging.'
How Secondary Hypogonadism Symptoms Compare to Primary
The day-to-day symptom experience of secondary hypogonadism — fatigue, low libido, reduced muscle mass, mood changes, absent morning erections — is essentially identical to primary hypogonadism, since both ultimately produce the same low testosterone that drives these symptoms. What differs isn't how it feels, but what it means diagnostically and what else needs to be ruled out. Because secondary hypogonadism signals a problem upstream in the pituitary or hypothalamus rather than in the testes themselves, it sometimes comes bundled with additional symptoms specific to the underlying cause — galactorrhea (unexpected nipple discharge) with hyperprolactinemia, headaches or visual field changes with a larger pituitary tumor, or a complete absence of puberty and sense of smell with congenital Kallmann syndrome. Recognizing these additional, non-testosterone-related symptoms is often what tips a workup toward investigating the pituitary specifically rather than treating the case as routine, testicular-origin low T.
Why Obesity Is the Most Common but Most Overlooked Cause
Obesity-related secondary hypogonadism deserves particular attention because it's simultaneously the most common cause and the one most likely to be misattributed to something else entirely — a man might be told his fatigue and low libido are 'just' a consequence of being overweight in a general, vague sense, rather than understanding the specific mechanism at play. Visceral fat disrupts the pulsatile release of GnRH from the hypothalamus, directly reducing the signal that drives testosterone production, while simultaneously converting more testosterone to estrogen through aromatase activity — a double hit to the hormonal system. The genuinely useful clinical point is that this specific pathway is meaningfully reversible: weight loss in the range of 10-15% of body weight has been shown to substantially improve or normalize testosterone in a large proportion of obese men with secondary hypogonadism, without requiring any hormone therapy at all. This makes obesity-driven secondary hypogonadism one of the more hopeful diagnoses in this category — the underlying cause is identifiable, common, and addressable through a well-understood intervention, rather than requiring lifelong medical management.
Causes of Secondary Hypogonadism
- •Obesity and metabolic syndrome: most common reversible cause — visceral fat disrupts GnRH pulsatility
- •Opioid use (opioid-induced androgen deficiency): opioids suppress GnRH and LH release; affects 50-90% of long-term opioid users
- •Hyperprolactinemia: elevated prolactin suppresses GnRH — pituitary adenoma most common cause; causes low T + galactorrhea
- •Glucocorticoid excess (exogenous or Cushing's): suppresses GnRH and LH directly
- •Iron overload (hemochromatosis): iron deposits in pituitary impair LH secretion — screen with ferritin
- •Pituitary tumors (macroadenomas): mass effect or hormonal disruption; MRI required if LH/FSH low
- •Kallmann syndrome: congenital GnRH deficiency — presents with anosmia (no sense of smell) + lack of puberty
- •Traumatic brain injury: damages hypothalamic-pituitary axis — increasingly recognized in TBI patients
Why Treatment Sometimes Differs
For reversible causes (obesity, opioids), treating the cause can normalize testosterone without TRT. For men with secondary hypogonadism who wish to preserve fertility, gonadotropin therapy (hCG + FSH) stimulates testicular testosterone production while maintaining spermatogenesis — TRT suppresses LH and stops sperm production. Clomiphene citrate (a SERM) stimulates endogenous LH release and can raise T while preserving fertility in secondary hypogonadism.
How Gonadotropin Therapy Actually Works
It's worth understanding the mechanism behind fertility-preserving treatment for secondary hypogonadism, since it's genuinely different from standard TRT and explains why it's preferred when fertility matters. hCG (human chorionic gonadotropin) mimics LH directly, binding to the same testicular receptors LH normally activates and stimulating the testes to produce testosterone using their own intact machinery — since in secondary hypogonadism, the testes themselves are healthy and fully capable, they're just not being told to work. This is fundamentally different from TRT, which delivers testosterone from outside the body and, in doing so, actually suppresses the body's own LH production further through negative feedback, shutting down natural testicular function and sperm production entirely. For men who need both testosterone correction and fertility preservation, hCG (sometimes combined with FSH to directly support sperm production) achieves both simultaneously, while TRT achieves only the first at the cost of the second. This is why the fertility conversation needs to happen before treatment starts, not after — switching from TRT back to a fertility-preserving protocol later is possible but adds delay and complexity that could have been avoided with the right initial choice.
ManCore's free daily log tracks energy, libido, sleep, and mood — the symptoms most affected by low testosterone — so you can see real trends instead of guessing.
Track This Biomarker — Free
Don't let a number on a lab report disappear into a drawer. Log it in ManCore's biomarker tracker and watch how it trends over months as you adjust training, diet, and sleep.
Supplements for Testosterone Support
Male Optimization Formula
Formulated around ashwagandha and other ingredients studied for testosterone support.
Snap Supplements Nitric Oxide Booster + Prostate Health
Supports healthy circulation alongside a testosterone-focused routine.
Affiliate disclosure: ManCore earns a small commission on purchases made through these links at no extra cost to you.
Frequently Asked Questions
What is secondary hypogonadism?
Secondary hypogonadism (hypogonadotropic hypogonadism) is low testosterone caused by pituitary or hypothalamic dysfunction — the testes are capable of producing testosterone but don't receive adequate LH signal. Diagnosed by: low testosterone + low or inappropriately normal LH. Common causes: obesity, opioids, hyperprolactinemia, hemochromatosis, pituitary tumors.
How is secondary hypogonadism treated differently from primary?
For reversible causes, treat the underlying condition first (weight loss for obesity, opioid dose reduction). For fertility: gonadotropin therapy (hCG ± FSH) or clomiphene — preserve sperm production unlike TRT. For men not seeking fertility with confirmed secondary hypogonadism, TRT works as well as for primary, but pituitary causes (tumors, hemochromatosis, hyperprolactinemia) must be identified and treated regardless.
Is secondary hypogonadism curable?
Depends on cause. Obesity-related secondary hypogonadism: often reversible with 10–15% weight loss. Opioid-induced: recovers with opioid discontinuation (may take months). Hyperprolactinemia from microadenoma: typically curable with dopamine agonists (cabergoline). Macroadenoma: may require surgery. Congenital (Kallmann): requires lifelong treatment. Many cases are fully reversible.
What is Kallmann syndrome, and how is it different from other causes?
Kallmann syndrome is a congenital (present from birth) form of secondary hypogonadism caused by GnRH-producing neurons failing to migrate properly during fetal development, classically presenting with absent or delayed puberty alongside anosmia (no sense of smell) — a distinctive combination that helps distinguish it from the acquired causes (obesity, opioids, tumors) that develop later in life. Unlike many acquired causes, Kallmann syndrome isn't reversible through lifestyle change, since the underlying neurological wiring issue is structural, requiring lifelong hormone therapy, though fertility can often still be achieved with gonadotropin therapy when desired.
How does hyperprolactinemia specifically cause secondary hypogonadism?
Elevated prolactin directly suppresses GnRH release from the hypothalamus, which in turn reduces LH output from the pituitary, ultimately lowering testosterone through the same pathway other secondary causes use. Prolactin-secreting pituitary tumors (prolactinomas) are the most common cause of clinically significant hyperprolactinemia, and the classic accompanying sign in men is galactorrhea (unexpected nipple discharge), though many men with hyperprolactinemia never notice this and are diagnosed only through bloodwork done for low-T symptoms.
Can secondary hypogonadism cause symptoms beyond the usual low-T picture?
Yes, depending on the specific cause — a pituitary tumor large enough to press on surrounding structures can cause headaches or visual field defects (since the pituitary sits near the optic nerves), traumatic brain injury-related cases may come with other neurological or cognitive symptoms from the underlying injury, and hemochromatosis-related cases often come with the broader iron-overload symptom picture (joint pain, fatigue, skin changes). These additional symptoms are important clues that point toward a pituitary or systemic cause needing its own specific workup and treatment, not just standard testosterone management.
How common is secondary hypogonadism compared to primary?
In men over 40, secondary hypogonadism is generally more common than primary, driven largely by the high prevalence of obesity, metabolic syndrome, and other acquired causes in this population. Primary hypogonadism, while less common overall, is proportionally more significant in younger men, particularly those with a genetic cause like Klinefelter syndrome or a history of testicular cancer treatment — which is why age and history both factor into how a doctor weighs the likelihood of each type before the LH test result even comes back.
Can secondary hypogonadism resolve on its own without any treatment?
In some cases, yes — mild, recently-developed cases tied to a clearly identifiable and reversible trigger (a short course of high-dose steroids, a brief period of significant weight gain, temporary heavy alcohol use) can resolve once the trigger is removed, without requiring ongoing medical treatment. Longer-standing or more severe cases, and those with a structural cause like a pituitary tumor, typically need active treatment rather than spontaneous resolution over time.
Does secondary hypogonadism require lifelong monitoring even after successful treatment?
For reversible causes that fully resolve (obesity-related, opioid-related), periodic rechecking is reasonable but ongoing intensive monitoring usually isn't necessary once normal levels are confirmed stable. For structural or congenital causes, ongoing monitoring is typically part of long-term management regardless of treatment response.